Mike Miliard is Editor of Healthcare IT News. Mike covers topics such as health information exchange, privacy and security, analytics, ICD-10 and is responsible for overall coverage decisions. Follow Mike on Twitter @MikeMiliardHITN.
By Mike Miliard 02:47 pm September 20, 2017
Having long been disappointed in the level of attention paid to that EHR, small hospital clients are hopeful Allscripts will make the investments necessary to improve it.
By Mike Miliard 02:53 pm September 19, 2017
Doctella gives hospitals, practices and insurers templates to create customized apps that might otherwise cost more than $500,000 and require teams of developers.
By Mike Miliard 02:19 pm September 18, 2017
Thousands of people in Florida and Texas have made use of remote consults offered by Nemours and others.
By Mike Miliard 10:26 am September 18, 2017
By giving patients control over their data, the technology could enable better privacy protections, more efficiency and easier information exchange.
By Mike Miliard 03:36 pm September 14, 2017
APIs bring third-party analytics tools into the Epic platform, helping hospitals get more out of EHR investments, hospital CIO says.
By Mike Miliard 01:33 pm September 13, 2017
Manufacturers must also work to continually assess new cyber risks to the medical devices on the market.
By Mike Miliard 01:10 pm September 08, 2017
OnBase Mackinac enables easier collaboration, expedited document sharing between providers and payers, Hyland says.
By Mike Miliard 11:37 am September 07, 2017
Manufacturers should make safe connectivity a central part of their design process and clearly communicate devices' interface characteristics, the agency says.
By Mike Miliard 03:48 pm September 06, 2017
As it works to shore up its client base, Allscripts will have to differentiate itself from Epic and Cerner by showing lower total cost of ownership and a commitment open data sharing.
By Mike Miliard 03:35 pm September 05, 2017
The Clinical Decision Support Coalition’s suggestions are focused on the design and development of medium-risk tools for decision support that don't fall under FDA purview.